AMXI-5001 is a potent, orally active dual inhibitor of PARP1/2 and microtubule polymerization. This compound demonstrates selective antitumor cytotoxicity in various human cancer cell lines, exhibiting lower IC50 values compared to existing clinical PARP inhibitors. AMXI-5001 is capable of inducing complete regression of established tumors, including those of considerable size, making it a promising candidate for cancer research and therapeutic development.
AMXI-5001 is a potent, orally active dual inhibitor of PARP1/2 and microtubule polymerization. This compound demonstrates selective antitumor cytotoxicity in various human cancer cell lines, exhibiting lower IC50 values compared to existing clinical PARP inhibitors. AMXI-5001 is capable of inducing complete regression of established tumors, including those of considerable size, making it a promising candidate for cancer research and therapeutic development.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
